phenytoin has been researched along with nifedipine in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (16.19) | 18.7374 |
1990's | 37 (35.24) | 18.2507 |
2000's | 24 (22.86) | 29.6817 |
2010's | 26 (24.76) | 24.3611 |
2020's | 1 (0.95) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Antkiewicz-Michaluk, L; Marona, H; Pekala, E; Szneler, E; Walczak, M | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Sen, S; Sinha, N | 1 |
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Bharathi, K; Prasad, KV; Prasanthi, G | 2 |
Brouillette, WJ; Brown, GB; Zha, C | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Hashiguchi, M; Hashiguchi, T; Kanazawa, M; Miyazaki, T; Sakai, S; Tosaka, T | 1 |
Bernimoulin, JP; Hinz, N; Romanos, GE; Schröter-Kermani, C | 1 |
Danielson, M; Danielsson, BR; Reiland, S; Rundqvist, E | 1 |
Beaver, WT; Bottomley, WK; Brown, RS | 1 |
Kano, M; Nakabayashi, Y; Satoh, R | 1 |
Bosker, H; Jordan, RD; Koole, R; Sindet-Pedersen, S | 1 |
Bahls, FH; Ozuna, J; Ritchie, DE | 1 |
Breimer, DD; Hoevers, JW; Schellens, JH; Soons, PA; van der Wart, JH | 1 |
Røed, A | 1 |
Hahn, G; Menard, MR | 1 |
Kano, M; Kudo, Y; Suzuki, N; Takagi, H; Tanakadate, A; Yoshioka, T | 1 |
Oikarinen, AI; Oikarinen, KS; Salo, T | 1 |
Carpenter, CL; Greenberg, DA; Messing, RO | 1 |
Calixto, JB | 1 |
Gerthoffer, WT; Shafer, PG; Taylor, S | 1 |
Lundergan, WP | 1 |
Dretchen, KL; Henderson, TR; Raines, A | 1 |
Ferrés, E; López Colomés, JL; Moreno, A; Villena, J | 1 |
Bruno, P; Bylund, DB; Harris, RA; Jones, SB | 1 |
Bencini, L; Marini, D; Piferi, M; Sala, F; Silvestri, E; Veraldi, S | 1 |
Yusof, WZ | 1 |
Butler, RT; Kaldahl, WB; Kalkwarf, KL | 1 |
Ciancio, SG | 1 |
Howell, LP; Lucas, RM; Wall, BA | 1 |
Carpenter, CL; Cooper, EC; Greenberg, DA | 1 |
Connolly, SM | 1 |
Ahmad, S | 1 |
Lazarus, LH; Spracklen, FH | 1 |
Levine, RA; Rees, TD | 1 |
Ben-Chitrit, S; Bernheim, J; Korzets, Z | 1 |
Bliesath, H; Hartmann, M; Huber, R; Radtke, HW; Steinijans, VW; Wurst, W; Zech, K | 1 |
Ullal, GR | 1 |
Akimoto, Y; Fujii, A; Matsumoto, H; Nakao, S; Teshigawara, H | 1 |
Ikeda, M; Kamata, R; Kasamo, K; Kojima, T; Nogami, Y; Okuhata, Y; Satoh, R; Takahashi, S | 1 |
Oda, Y; Okada, Y; Shikata, H; Shimojima, T; Utsumi, N | 1 |
Bernimoulin, JP; Romanos, GE; Strub, JR | 1 |
Pleuvry, BJ; Rodger, C | 1 |
Knowles, GC; McCulloch, CA | 1 |
Ishida, H; Morisaki, I; Nagata, T; Nishikawa, S; Oka, T | 1 |
Berini, L; Brunet, L; Farré, M; Mendieta, C; Miranda, J | 1 |
Iwakura, M; Mori, S; Saito, K; Sakamoto, S | 1 |
Satishchandra, P; Shankar, SK; Ullal, GR | 1 |
Inoue, K; Mimura, M; Nakamura, S; Oda, H; Ohmori, S; Shimada, T; Yamazaki, H | 1 |
Slezák, R | 1 |
Abu-el-Dahab, O; el-Sherbiny, MM; Fathy, LM; Shoieb, MA | 1 |
Botha, PJ | 1 |
Desai, P; Silver, JG | 1 |
Hall, EE | 1 |
Gopalakrishna, HN; Raju, SS; Venkatadri, N | 1 |
Blaisdell, J; Dalton, JT; Goldstein, JA; Kidd, RS; Meyer, MC; Straughn, AB | 1 |
Dokoumetzidis, A; Macheras, P; Valsami, G | 1 |
Mori, S; Saito, K; Sakamoto, S; Tanda, N | 2 |
Dongari-Bagtzoglou, AI; Morton, RS | 1 |
Kokue, E; Saitoh, T; Shimoda, M | 1 |
Manley, SW; Mitchell, AM; Mortimer, RH; Powell, KA | 1 |
Firatli, E; Hong, HH; Kantarci, A; Sheff, MC; Trackman, PC; Uygur, C; Uzel, MI | 1 |
Lowenthal, A; Lowenthal, MN | 1 |
Akimoto, Y; Fujii, A; Matsumoto, H; Noji, I | 1 |
Kantarci, A; Trackman, PC | 1 |
Inoue, T; Kizawa, Y; Murakami, H; Ohuchi, N; Sano, M; Tachikawa, T; Tono, K | 1 |
Marks, B; Raucy, J; Trubetskoy, O; Yueh, MF; Zielinski, T | 1 |
de Morais, SM; Fahmi, OA; Liras, JL; Maurer, TS; Mills, JB; Ripp, SL; Trevena, KA | 1 |
Buduneli, E; Buduneli, N; Cinar, S; Kinane, DF; Lappin, D | 1 |
Augustin, P; Firatli, E; Graves, DT; Hasturk, H; Kantarci, A; Sheff, MC; Trackman, PC | 1 |
Castro, AL; Crivelini, MM; Garcia, JF; Kanno, CM; Oliveira, JA | 1 |
Bhattacharyya, I; Cohen, D | 1 |
Chou, D; Duley, L; Henderson-Smart, DJ | 1 |
Kantarci, A; Kim, YS; Nseir, Z; Sume, SS; Trackman, PC | 1 |
Ashrafi, SS; Nakib, N | 1 |
De Gusmao, C; Echeverria, Y; Forteza, A; Gutierrez, J; Haussen, DC; Wiley, E | 1 |
Nilsson, MF; Ritchie, H; Webster, WS | 1 |
Bian, Z; Fang, YJ; Meng, LY; Tay, FR; Zhao, XH | 1 |
Ervolino, E; Kanno, CM; Oliveira, JA; Soubhia, AMP | 1 |
Song, J; Wang, X; Wu, J; Zhang, R; Zhu, J | 1 |
15 review(s) available for phenytoin and nifedipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
On the mechanism of drug-induced gingival hyperplasia.
Topics: Dental Plaque; Diltiazem; Epidermal Growth Factor; Fibroblasts; Folic Acid; Gingival Hyperplasia; Glycosaminoglycans; Humans; Immunoglobulin Isotypes; Microbial Collagenase; Nifedipine; Phenytoin | 1991 |
Scleroderma: therapeutic options.
Topics: Alprostadil; Captopril; Colchicine; Griseofulvin; Humans; Immunosuppressive Agents; Nifedipine; Penicillamine; Phenytoin; Physical Therapy Modalities; Plasmapheresis; Prostaglandins E; Scleroderma, Systemic; Vasodilator Agents | 1984 |
Systematic drugs as a risk factor for periodontal disease initiation and progression.
Topics: Calcium Channel Blockers; Cyclosporine; Female; Fibromatosis, Gingival; Gingival Hyperplasia; Gonadal Steroid Hormones; Humans; Male; Nifedipine; Phenytoin | 1995 |
Lack of pantoprazole drug interactions in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin | 1994 |
Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model.
Topics: Age Factors; Animals; Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Dental Plaque; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Gingival Hyperplasia; Gingivitis; Humans; Immunosuppressive Agents; Male; Nifedipine; Phenytoin; Rats; Rats, Inbred F344; Sex Factors; Specific Pathogen-Free Organisms | 1996 |
Gingival enlargement induced by drugs.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin | 1996 |
Drug-induced gingival overgrowth after phenytoin and nifedipine therapy. A case report.
Topics: Anticonvulsants; Calcium Channel Blockers; Drug Therapy, Combination; Female; Gingival Overgrowth; Humans; Middle Aged; Nifedipine; Periodontitis; Phenytoin; Tooth Extraction | 1997 |
Drug-induced gingival hyperplasia and its management--a literature review.
Topics: Anticonvulsants; Calcium Channel Blockers; Clinical Protocols; Cyclosporine; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin | 1997 |
Drug-induced gingival enlargements.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Overgrowth; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin; Verapamil | 1998 |
Prevention and treatment considerations in patients with drug-induced gingival enlargement.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Dental Prophylaxis; Gingival Overgrowth; Gingivectomy; Humans; Immunosuppressive Agents; Nifedipine; Oral Hygiene; Phenytoin | 1997 |
Connective tissue metabolism and gingival overgrowth.
Topics: Animals; Anticonvulsants; Antihypertensive Agents; Connective Tissue; Connective Tissue Growth Factor; Cyclosporine; Extracellular Matrix; Fibroblasts; Gingival Overgrowth; Growth Substances; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Nifedipine; Phagocytosis; Phenytoin | 2004 |
Magnesium sulphate versus phenytoin for eclampsia.
Topics: Anticonvulsants; Clonazepam; Diazepam; Drug Combinations; Eclampsia; Female; Humans; Magnesium Sulfate; Nifedipine; Phenytoin; Pregnancy; Randomized Controlled Trials as Topic | 2010 |
Drug-induced gingival overgrowth.
Topics: Adult; Anticonvulsants; Calcium Channel Blockers; Child; Cyclosporine; Gingiva; Gingival Overgrowth; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin; Prevalence; Risk Factors | 2011 |
Bibliometric analysis of research trends and characteristics of drug-induced gingival overgrowth.
Topics: Amlodipine; Anticonvulsants; Bibliometrics; Calcium Channel Blockers; Cyclosporine; Gingival Overgrowth; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin | 2022 |
2 trial(s) available for phenytoin and nifedipine
Article | Year |
---|---|
Lack of pharmacokinetic interaction between nifedipine, sparteine and phenytoin in man.
Topics: Administration, Oral; Adult; Drug Interactions; Female; Humans; Male; Nifedipine; Oxidation-Reduction; Phenytoin; Sparteine | 1991 |
Lack of pantoprazole drug interactions in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin | 1994 |
89 other study(ies) available for phenytoin and nifedipine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Anticonvulsant activity of some xanthone derivatives.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Mice; Molecular Structure; Pentylenetetrazole; Rats; Seizures; Xanthones | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
Design, synthesis and evaluation of dialkyl 4-(benzo[d][1,3]dioxol-6-yl)-1,4-dihydro-2,6-dimethyl-1-substituted pyridine-3,5-dicarboxylates as potential anticonvulsants and their molecular properties prediction.
Topics: Absorption; Analgesics; Animals; Anticonvulsants; Antioxidants; Chemistry Techniques, Synthetic; Drug Design; Male; Mice; Pyridines; Rats | 2013 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
Synthesis, anticonvulsant activity and molecular properties prediction of dialkyl 1-(di(ethoxycarbonyl)methyl)-2,6-dimethyl-4-substituted-1,4-dihydropyridine-3,5-dicarboxylates.
Topics: Administration, Oral; Animals; Anticonvulsants; Dihydropyridines; Drug Design; Male; Mice; Molecular Structure; Rats; Rats, Wistar; Seizures; Structure-Activity Relationship; Toxicity Tests, Acute | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Phenytoin partially antagonized L-type Ca2+ current in glucagon-secreting tumor cells (ITC-1).
Topics: Animals; Barium; Calcium; Calcium Channels; Cricetinae; Electrophysiology; Glucagon; Lanthanum; Membrane Potentials; Mesocricetus; Nifedipine; Phenytoin; Tumor Cells, Cultured | 1992 |
Distribution of fibronectin in healthy, inflamed and drug-induced gingival hyperplasia.
Topics: Actin Cytoskeleton; Adult; Connective Tissue; Connective Tissue Cells; Cyclosporine; Dental Plaque; Epithelium; Female; Fibronectins; Fluorescent Antibody Technique; Gingiva; Gingival Hemorrhage; Gingival Hyperplasia; Gingival Pocket; Gingivitis; Humans; Male; Middle Aged; Nifedipine; Phenytoin | 1992 |
Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity.
Topics: Abnormalities, Drug-Induced; Animals; Blood Vessels; Female; Fetal Hypoxia; Gestational Age; Heart Rate; Humans; Nifedipine; Phenytoin; Pregnancy; Rabbits; Toes | 1992 |
Pharmacological properties of two types of calcium channel in embryonic chick skeletal muscle cells in culture.
Topics: Action Potentials; Animals; Calcium Channels; Cations; Cells, Cultured; Chick Embryo; Gallopamil; Kinetics; Mollusk Venoms; Muscles; Nifedipine; omega-Conotoxins; Peptides, Cyclic; Phenytoin | 1991 |
The transmandibular implant: a 13-year survey of its use.
Topics: Adult; Aged; Aged, 80 and over; Dental Implantation, Endosseous; Female; Follow-Up Studies; Gingival Hyperplasia; Humans; Male; Mandibular Injuries; Middle Aged; Nifedipine; Pain; Phenytoin; Pipemidic Acid; Prognosis; Prosthesis Failure; Skin Transplantation; Surgical Wound Infection; Wounds, Nonpenetrating | 1991 |
Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Carbamazepine; Diltiazem; Drug Interactions; Female; Humans; Male; Middle Aged; Nifedipine; Phenytoin; Retrospective Studies; Seizures; Verapamil | 1991 |
Selective potentiation of subtetanic and tetanic contractions by the calcium-channel antagonist nifedipine in the rat diaphragm preparation.
Topics: Animals; Caffeine; Calcium; Diaphragm; Electric Stimulation; Female; In Vitro Techniques; Male; Membranes; Muscle Contraction; Nifedipine; Phenytoin; Potassium; Quinine; Rats; Rats, Inbred Strains; Respiratory Muscles | 1991 |
Acute and chronic hypothermia in a man with spinal cord injury: environmental and pharmacologic causes.
Topics: Adult; Autonomic Nervous System; Body Temperature Regulation; Humans; Hypothermia; Male; Nifedipine; Phenytoin; Spinal Cord Injuries | 1991 |
Participation of transient-type Ca2+ channels in the sustained increase of Ca2+ level in GH3 cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Electric Conductivity; In Vitro Techniques; Membrane Potentials; Nickel; Nifedipine; omega-Conotoxin GVIA; Peptides, Cyclic; Phenytoin; Pituitary Gland; Rats; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured; Verapamil | 1990 |
Effect of phenytoin and nifedipine on collagen gene expression in human gingival fibroblasts.
Topics: Adolescent; Blotting, Northern; Cell Division; Cells, Cultured; Child; Collagen; Fibroblasts; Gene Expression; Gingiva; Humans; Matrix Metalloproteinase 9; Microbial Collagenase; Nifedipine; Nucleic Acid Hybridization; Phenytoin; Protein Biosynthesis; RNA, Messenger | 1990 |
Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Topics: Adrenal Gland Neoplasms; Animals; Binding Sites; Calcium; Calcium Channel Blockers; Carbachol; Cell Line; Cinnarizine; Diltiazem; Flunarizine; Ion Channels; Nicotinic Acids; Nifedipine; Nimodipine; Nitrendipine; Phenytoin; Pheochromocytoma; Potassium; Rats; Sodium; Verapamil | 1985 |
Effect of diphenylhydantoin on drug and calcium induced contractions of isolated rat uterus: a comparative study with nifedipine.
Topics: Acetylcholine; Animals; Calcium; Female; In Vitro Techniques; Ion Channels; Nifedipine; Oxytocin; Phenytoin; Rats; Time Factors; Uterine Contraction | 1987 |
Selectivity of phenytoin and dihydropyridine calcium channel blockers for relaxation of the basilar artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Basilar Artery; Calcium; Calcium Channel Blockers; Dinoprost; Dogs; Dose-Response Relationship, Drug; Nifedipine; Phenytoin; Potassium; Prostaglandins F; Serotonin; Vasoconstriction; Vasodilation | 1987 |
Drug-induced gingival enlargements.
Topics: Adult; Cyclosporins; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Phenytoin | 1989 |
Effects of calcium channel blocking agents on neostigmine-induced fasciculations.
Topics: Animals; Calcium Channel Blockers; Electric Stimulation; Facial Muscles; Fasciculation; Male; Neostigmine; Nerve Endings; Nifedipine; Nitrendipine; Phenytoin; Rats; Rats, Inbred Strains; Verapamil | 1989 |
[Gingival hyperplasia associated with nifedipine].
Topics: Adult; Gingival Hyperplasia; Humans; Male; Nifedipine; Phenytoin | 1989 |
Effects of dihydropyridine derivatives and anticonvulsant drugs on [3H]nitrendipine binding and calcium and sodium fluxes in brain.
Topics: Animals; Anticonvulsants; Barbiturates; Brain; Calcium; Ethanol; In Vitro Techniques; Kinetics; Male; Nifedipine; Nitrendipine; Phenytoin; Rats; Rats, Inbred Strains; Sodium; Tritium | 1985 |
[Gingival hyperplasia due to diphenylhydantoin, cyclosporin A and nifedipine. A histopathological comparison].
Topics: Biopsy; Connective Tissue; Cyclosporins; Gingiva; Gingival Hyperplasia; Humans; Nifedipine; Phenytoin | 1988 |
Gingival hyperplasia: an intra-oral side effect of phenytoin, nifedipine and cyclosporine therapies.
Topics: Adult; Cyclosporins; Female; Gingival Hyperplasia; Humans; Nifedipine; Phenytoin | 1988 |
Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine.
Topics: Adult; Child; Cyclosporins; Female; Gingival Hyperplasia; Humans; Male; Nifedipine; Phenytoin | 1987 |
Drugs in dentistry. Medications for gingival hyperplasia.
Topics: Cyclosporins; Gingival Hyperplasia; Humans; Nifedipine; Phenytoin | 1987 |
Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study.
Topics: Acid Phosphatase; Adult; Aged; Alcian Blue; Female; Fibroblasts; Gingiva; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Phenytoin | 1985 |
Phenytoin interacts with calcium channels in brain membranes.
Topics: Animals; Brain; Calcium; Carbamazepine; Clonazepam; In Vitro Techniques; Ion Channels; Male; Nifedipine; Nitrendipine; Phenobarbital; Phenytoin; Rats; Valproic Acid | 1984 |
Nifedipine--phenytoin interaction.
Topics: Drug Interactions; Epilepsy, Tonic-Clonic; Humans; Male; Middle Aged; Nifedipine; Phenytoin | 1984 |
Nifedipine for digitalis-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Nifedipine; Phenytoin; Pyridines; Strophanthins; Verapamil | 1980 |
Bradycardia as a presenting feature of late postpartum eclampsia.
Topics: Adult; Bradycardia; Drug Therapy, Combination; Eclampsia; Female; Humans; Magnesium Sulfate; Nifedipine; Phenobarbital; Phenytoin; Pregnancy; Puerperal Disorders; Time Factors | 1994 |
Dihydropyridine group of calcium channel antagonist in epilepsy.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Electrodes, Implanted; Electroencephalography; Electroshock; Epilepsy; Hippocampus; Kindling, Neurologic; Male; Nifedipine; Phenytoin; Rats; Rats, Wistar | 1994 |
Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders.
Topics: Adult; Aged; Calcium Channel Blockers; Cell Count; Cell Division; Cells, Cultured; Collagen; DNA; Female; Fibroblasts; Gingiva; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Phenytoin | 1994 |
Chronological changes of MRI findings on striatal damage after acute cyanide intoxication: pathogenesis of the damage and its selectivity, and prevention for neurological sequelae: a case report.
Topics: Adult; Basal Ganglia; Brain Diseases; Carbamazepine; Corpus Striatum; Epilepsy, Temporal Lobe; Humans; Magnetic Resonance Imaging; Male; Nifedipine; Phenobarbital; Phenytoin; Potassium Cyanide; Suicide, Attempted | 1993 |
Increased expression of type VI collagen genes in drug-induced gingival enlargement.
Topics: Animals; Blotting, Northern; Cells, Cultured; Collagen; Fibroblasts; Gene Expression; Gingival Diseases; Humans; Immunohistochemistry; Nifedipine; Phenytoin; Rabbits; Rats; RNA, Messenger | 1993 |
Immunohistochemical distribution of extracellular matrix proteins as a diagnostic parameter in healthy and diseased gingiva.
Topics: Adult; Aged; Collagen; Cyclosporine; Extracellular Matrix Proteins; Female; Fibronectins; Fluorescent Antibody Technique; Gingiva; Gingival Hyperplasia; Gingivitis; Glycoproteins; Humans; Immunohistochemistry; Male; Microscopy, Fluorescence; Middle Aged; Nifedipine; Phenytoin | 1993 |
Protective effect of flunarizine and nifedipine alone and in combination with anticonvulsant drugs against PTZ-induced seizures in mice.
Topics: Animals; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Ethosuximide; Female; Flunarizine; Male; Mice; Nifedipine; Pentylenetetrazole; Phenytoin; Seizures | 1993 |
Deficiencies in collagen phagocytosis by human fibroblasts in vitro: a mechanism for fibrosis?
Topics: Adolescent; Adult; Cell Division; Cell Line; Collagen; Fibroblasts; Fibrosis; Flow Cytometry; Fluorescent Dyes; Gingiva; Humans; Microscopy, Electron, Scanning; Microspheres; Nifedipine; Phagocytosis; Phenytoin | 1993 |
Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Calcium Channel Blockers; Cell Count; Coloring Agents; Female; Fibroblast Growth Factor 2; Gingiva; Gingival Hyperplasia; Heparitin Sulfate; Humans; Immunohistochemistry; Male; Nifedipine; Phenytoin; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta | 1996 |
Effect of antiepileptic drugs and calcium channel blocker on hyperthermic seizures in rats: animal model for hot water epilepsy.
Topics: Animals; Anticonvulsants; Body Temperature; Calcium Channel Blockers; Disease Models, Animal; Electroencephalography; Epilepsy; Hippocampus; Hyperthermia, Induced; Injections, Intraperitoneal; Male; Nifedipine; Phenobarbital; Phenytoin; Rats; Rats, Wistar; Seizures | 1996 |
Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
Topics: Adrenergic beta-Antagonists; Aniline Compounds; Animals; Antineoplastic Agents; Benzphetamine; Carcinogens; Coumarins; Cytochrome P-450 Enzyme System; Dogs; Erythromycin; Ethanolamines; Ethylmorphine; Guinea Pigs; Humans; Macaca fascicularis; Mephenytoin; Microsomes, Liver; Nifedipine; Oxazines; Oxidation-Reduction; Phenacetin; Phenytoin; Rats; Species Specificity | 1997 |
A clinical and histological comparative study of the effect of nifedipine and phenytion on human gingiva.
Topics: Anticonvulsants; Biopsy; Calcium Channel Blockers; Gingiva; Gingival Hyperplasia; Humans; Nifedipine; Phenytoin; Time Factors | 1993 |
Effect of propranolol and nifedipine on maximal electroshock-induced seizures in mice: individually and in combination.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Male; Mice; Nifedipine; Phenytoin; Propranolol; Rats; Rats, Wistar; Seizures | 1998 |
Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele.
Topics: Adult; Alleles; Aryl Hydrocarbon Hydroxylases; Chlorpheniramine; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Genotype; Glipizide; Homozygote; Humans; Male; Nifedipine; Phenotype; Phenytoin; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 1999 |
Modeling of supersaturated dissolution data.
Topics: Chemistry, Pharmaceutical; Models, Chemical; Nifedipine; Phenytoin; Solutions | 1999 |
Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin.
Topics: Adolescent; Adult; Anticonvulsants; Biomarkers, Tumor; Calcium Channel Blockers; Carcinoma, Squamous Cell; Cells, Cultured; Culture Techniques; DNA Damage; Female; Fibroblasts; Gingival Hyperplasia; Gingival Neoplasms; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Middle Aged; Nifedipine; Phenytoin; Tumor Suppressor Protein p53 | 1999 |
Regulation of gingival fibroblast interleukin-6 secretion by cyclosporine A.
Topics: Anticonvulsants; Bacteria; Calcium Channel Blockers; Cell Division; Cells, Cultured; Cyclosporine; Down-Regulation; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gingiva; Gingival Overgrowth; Humans; Immunosuppressive Agents; Interleukin-1; Interleukin-6; Nifedipine; Phenytoin; Tumor Necrosis Factor-alpha; Up-Regulation | 1999 |
Immunolocalizaiton of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Calcium Channel Blockers; Epithelial Cells; Epithelium; Female; Gene Expression Regulation; Gingiva; Gingival Hyperplasia; Homeostasis; Humans; Immunoenzyme Techniques; Immunohistochemistry; Male; Middle Aged; Morphogenesis; Nifedipine; Phenytoin; Proto-Oncogene Mas; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc | 2000 |
The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antipyrine; Area Under Curve; Chromatography, High Pressure Liquid; Escherichia coli; Female; Half-Life; Injections, Intramuscular; Interleukin-6; Lipopolysaccharides; Metabolic Clearance Rate; Nifedipine; Phenytoin; Protein Binding; Rabbits; Theophylline; Vasodilator Agents | 2000 |
Different transporters for tri-iodothyronine (T(3)) and thyroxine (T(4)) in the human choriocarcinoma cell line, JAR.
Topics: Analysis of Variance; Biological Transport; Calcium Channel Blockers; Choriocarcinoma; Cyclooxygenase Inhibitors; Diazepam; Female; GABA Modulators; Humans; Iodine Radioisotopes; Leucine; Meclofenamic Acid; Mefenamic Acid; Nifedipine; Nitrendipine; Phenylalanine; Phenytoin; Thyroxine; Triiodothyronine; Tryptophan; Tumor Cells, Cultured; Uterine Neoplasms; Verapamil | 2000 |
Connective tissue growth factor in drug-induced gingival overgrowth.
Topics: Adult; Antibodies; Anticonvulsants; Calcium Channel Blockers; Carrier Proteins; Coloring Agents; Connective Tissue; Connective Tissue Growth Factor; Cyclosporine; Endothelium, Vascular; Epithelium; Female; Fibroblasts; Fibrosis; Gingival Overgrowth; Growth Substances; Humans; Image Processing, Computer-Assisted; Immediate-Early Proteins; Immunoenzyme Techniques; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Male; Middle Aged; Mitogens; Neovascularization, Pathologic; Nifedipine; Phenytoin; Platelet Endothelial Cell Adhesion Molecule-1; Statistics, Nonparametric; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Gingival hypertrophy due to drugs.
Topics: Adolescent; Anticonvulsants; Female; Gingival Hypertrophy; Humans; Male; Middle Aged; Nifedipine; Phenytoin; Tocolytic Agents | 2001 |
Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Calcium Channel Blockers; Cell Culture Techniques; Cell Division; Collagen; Diltiazem; DNA; ErbB Receptors; Female; Fibroblasts; Flow Cytometry; Gingiva; Gingival Overgrowth; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Nisoldipine; Phenytoin; Radiopharmaceuticals; Statistics as Topic; Tritium; Verapamil | 2001 |
Proliferative response to phenytoin and nifedipine in gingival fibroblasts cultured from humans with gingival fibromatosis.
Topics: Anticonvulsants; Antihypertensive Agents; Calcium Channel Blockers; Cells, Cultured; Endothelin-1; Fibroblasts; Fibromatosis, Gingival; Humans; Nifedipine; Peptides, Cyclic; Phenytoin | 2004 |
A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Chromans; Clotrimazole; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Dimethyl Sulfoxide; Enhancer Elements, Genetic; Enzyme Induction; Genes, Reporter; Genes, Synthetic; Humans; Ketoconazole; Liver Neoplasms; Lovastatin; Luciferases; Mifepristone; Neoplasm Proteins; Nifedipine; Omeprazole; Paclitaxel; Phenytoin; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Recombinant Fusion Proteins; Rifampin; Thiazolidinediones; Transcription, Genetic; Troglitazone; Troleandomycin | 2005 |
Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction.
Topics: Algorithms; Carbamazepine; Cell Line; Cell Proliferation; Cell Survival; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Hepatocytes; Humans; Nifedipine; Phenobarbital; Phenytoin; Pioglitazone; Reproducibility of Results; Rifampin; Rosiglitazone; Sulfinpyrazone; Thiazolidinediones | 2006 |
Immunohistochemical evaluation of Ki-67 expression and apoptosis in cyclosporin A-induced gingival overgrowth.
Topics: Adult; Analysis of Variance; Apoptosis; Calcium Channel Blockers; Case-Control Studies; Cell Proliferation; Cyclosporine; Female; Gingival Overgrowth; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Nick-End Labeling; Ki-67 Antigen; Kidney Transplantation; Male; Mitosis; Nifedipine; Phenytoin; Statistics, Nonparametric | 2007 |
Apoptosis in gingival overgrowth tissues.
Topics: Anticonvulsants; Apoptosis; Calcium Channel Blockers; Case-Control Studies; Caspase 3; Cell Proliferation; Cyclosporine; Fibroblasts; Fibromatosis, Gingival; Forkhead Box Protein O1; Forkhead Transcription Factors; Gingival Overgrowth; Gingivitis; Humans; Immunosuppressive Agents; In Situ Nick-End Labeling; Nifedipine; Phenytoin; Proliferating Cell Nuclear Antigen | 2007 |
Effects of cyclosporin, phenytoin, and nifedipine on the synthesis and degradation of gingival collagen in tufted capuchin monkeys (Cebus apella): histochemical and MMP-1 and -2 and collagen I gene expression analyses.
Topics: Animals; Anticonvulsants; Azo Compounds; Biopsy; Calcium Channel Blockers; Cebus; Collagen; Collagen Type I; Collagen Type IV; Coloring Agents; Cyclosporine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gingiva; Gingival Overgrowth; Gingivitis; Histocytochemistry; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Nifedipine; Phenytoin; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Case of the month: drug-induced hyperplasia.
Topics: Adult; Cyclosporine; Diagnosis, Differential; Female; Gingival Hyperplasia; Humans; Nifedipine; Phenytoin | 2008 |
Loss of basement membrane integrity in human gingival overgrowth.
Topics: Adult; Analysis of Variance; Basement Membrane; Case-Control Studies; Cell Adhesion Molecules; Collagen Type IV; Cyclosporine; Epithelial-Mesenchymal Transition; Female; Gene Expression; Gingival Overgrowth; Humans; Kalinin; Male; Nifedipine; Phenytoin; Statistics, Nonparametric; Young Adult | 2011 |
Cerebral vasomotor reactivity monitoring in posterior reversible encephalopathy syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Anticonvulsants; Calcium Channel Blockers; Diagnosis, Differential; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Nifedipine; Phenytoin; Posterior Leukoencephalopathy Syndrome; Ultrasonography, Doppler, Transcranial | 2010 |
Oral pathology quiz # 75. Case number 4. Systemic medication.
Topics: Anticonvulsants; Cyclosporine; Diagnosis, Differential; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Male; Middle Aged; Nifedipine; Phenytoin; Vasodilator Agents | 2012 |
The effect on rat embryonic heart rate of Na+, K+, and Ca2+ channel blockers, and the human teratogen phenytoin, changes with gestational age.
Topics: Animals; Calcium Channel Blockers; Female; Gestational Age; Heart Rate, Fetal; Lidocaine; Nifedipine; Phenethylamines; Phenytoin; Potassium Channel Blockers; Pregnancy; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Sulfonamides | 2013 |
Topical application of phenytoin or nifedipine-loaded PLGA microspheres promotes periodontal regeneration in vivo.
Topics: Administration, Topical; Alveolar Bone Loss; Animals; Biomarkers; Cyclosporine; Drug Carriers; Gingival Recession; Immunohistochemistry; Male; Microspheres; Nifedipine; Phenytoin; Polyesters; Random Allocation; Rats; Rats, Sprague-Dawley; Single-Blind Method; X-Ray Microtomography | 2019 |
Effects of cyclosporin, nifedipine and phenytoin on gingival myofibroblast transdifferentiation in monkeys.
Topics: Actins; Animals; Apoptosis; Biopsy; Cell Proliferation; Cell Transdifferentiation; Cyclosporine; Genes, bcl-2; Gingiva; Gingival Overgrowth; Haplorhini; Immunohistochemistry; Ki-67 Antigen; Longitudinal Studies; Male; Myofibroblasts; Nifedipine; Phenytoin; Random Allocation | 2018 |